Nuclear medicine in developing countries: Perspective from Iran

Journal of Nuclear Medicine

Volumn 51, Issue 5, 2010, Pages

  Gholamrezanezhad, Ali ^a   Mirpour, Sahar ^a   Bekbahani, Ali Akhavan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Majlis (Parliament) Research Center   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DEVELOPING COUNTRY; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DEVELOPING COUNTRIES; DIAGNOSTIC IMAGING; DIFFUSION OF INNOVATION; HEALTH CARE SURVEYS; IRAN; NATIONAL HEALTH PROGRAMS; NUCLEAR MEDICINE;

EID: 77952024218     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (34)

1. National Research Council. Advancing Nuclear Medicine Through Innovation. Washington, DC: National Academies Press; 2007.
2. Gholamrezanezhad A, Mirpour S, Mariani G. Future of nuclear medicine: SPECT versus PET. J Nucl Med. 2009;50[7]:16N-8N.
3. Rootwelt K. Henri Becquerel's discovery of radioactivity, and history of nuclear medicine. 100 years in the shadow or on the shoulder of Röntgen. Tidsskr Nor Laegeforen. 1996;116:3625-3629.
4. Palesh M, Fredrikson S, Jamshidi H, Jonsson PM, Tomson G. Diffusion of magnetic resonance imaging in Iran. Int J Technol Assess Health Care. 2007;23: 278-285. (Pubitemid 46642734)
5. You JJ, Alter DA, Iron K, et al. Diagnostic Services in Ontario: Descriptive Analysis and Jurisdictional Review. ICES Investigative Report. Toronto, Canada: Institute for Clinical Evaluative Sciences; 2007.
6. Canadian Institute for Health Information. Medical Imaging in Canada, 2007. Ottawa, Canada: Canadian Institute for Health Information; 2008.
7. Palesh M, Fredrikson S, Jamshidi H, Tomson G, Petzold M. How is magnetic resonance imaging used in Iran? Int J Technol Assess Health Care. 2008;24: 452-458.
8. University of Social Welfare and Rehabilitation Sciences (Tehran, Iran). Social Problem Database. Available at: www.spdb.uswr.ac.ir. Accessed on March 17, 2010.
9. Patton DD. The birth of nuclear medicine instrumentation: Blumgart and Yens, 1925. J Nucl Med. 2003;44[8]:1362-1365.
10. Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114:89-98.
11. Phelps ME, Hoffman EJ, Mullani NA, Ter-Pogossian MM. Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med. 1975;16:210-224.
12. Phelps ME, Hoffman EJ, Huang SC, Ter-Pogossian MM. Effect of positron range on spatial resolution. J Nucl Med. 1975;16:649-652.
13. United Nations Development Programs. Statistics of the Human Development Reports. Available at: http://hdr.undp.org/en/statistics. Accessed on March 17, 2010.
14. Duatti A. Promoting nuclear medicine in developing countries through IAEA coordinated research projects: Technical Reports Series 458 and 459. Q J Nucl Med Mol Imaging. 2008;52:209-211.
15. Mahal A, Varshney A, Taman S. Diffusion of diagnostic medical devices and policy implications for India. Int J Technol Assess Health Care. 2006;22:184-190.
16. Slade EP, Anderson GF. The relationship between per capita income and diffusion of medical technologies. Health Policy. 2001;58:1-14.
17. Grammaticos P. Problems especially for nuclear medicine: better to prevent than to treat. Hell J Nucl Med. 2005;8:93-94. (Pubitemid 41236583)
18. Hadjipavlidou V. Nuclear medicine equipment and PET cameras in Greece and abroad. Hell J Nucl Med. 2004;7:174. (Pubitemid 40185995)
19. Casey JT. Status Report and Analysis of Health Professional Regulations in Canada (prepared for the Federal/Provincial/Territorial Advisory Committee on Health Human Resources). Edmonton, Canada: Field Atkinson Perraton; 1999.
20. Sasaki Y. Status of positron emission tomography in Japan. Clin Positron Imaging. 1998;1:95-99. (Pubitemid 128784434)
21. Canadian Institute for Health Information. Medical Imaging in Canada. Ottawa, Canada: Canadian Institute for Health Information; 2007.
22. Lee M-C. Strategy for the promotion of nuclear medicine in developing countries. Presented at the Congress of the World Federation of Nuclear Medicine and Biology. Seoul, Korea: 2006.
23. Mut F. PET in Latin America: enthusiasm, challenges and precautions. Alasbimn J. 2004;6(25). Available at: http://www2.alasbimnjournal.cl/alasbimn/ CDA/sec-a/0,1205,SCID%253D11299%2526PRT%253D0,00.html. Accessed on March 17, 2010.
24. Conti PS, Keppler JS, Halls JM. Positron emission tomography: a financial and operational analysis. Am J Roentgenol. 1994;162:1279-1286. (Pubitemid 24187470)
25. Gholamrezanezhad A, Mirpour S. Scientific journalism and output of the iranian nuclear medicine community: the past, present and future. Iranian J Nucl Med. [In press]
26. Traylor J. Positron emission tomography: a first-hand experience. Radiol Manage. 2000;22:41-47.
27. Lissak RJ. The economics of creating a positron emission tomography center. Semin Nucl Med. 2000;30:299-305.
28. Siemens Medical Solutions. Medicare Coverage Codes for PET Imaging. Claim Form Submission Support. 2003. Available at: www.siemens.com/medical.
29. Tashiro M, Kubota K, Ito M, Fujimoto T, Yamaguchi K, Sasaki H, Moser E. Clinical PET activities in European and Asia-Oceanian countries. Kaku Igaku. 2001;38:255-267. (Pubitemid 33755702)
30. Lottes G, Gorschlüter P, Kuwert T, Adam D, Schober O. Costs of F-18-FDG PET: experience with a satellite concept. Nuklearmedizin. 1998;37:159-164. (Pubitemid 28385574)
31. Kouri BE, Parsons RG, Alpert HR. Physician self-referral for diagnostic imaging: review of the empiric literature. AJR Am J Roentgenol. 2002;179:843-850.
32. Abe K, Kosuda S, Kusano S. Medical economics of whole-body FDG PET in patients suspected of having non-small cell lung carcinoma-reassessment based on the revised Japanese national insurance reimbursement system. Ann Nucl Med. 2003;17:649-655. (Pubitemid 38196934)
33. Mitchell JM. Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California. Med Care. 2008;46:460-466.
34. Papatheofanis FJ. The willingness to pay for positron emission tomography (PET): evaluation of suspected lung cancer using contingent valuation. Q J Nucl Med. 2000;44:191-196.